J. Gajewski

1.4k total citations
17 papers, 1.0k citations indexed

About

J. Gajewski is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, J. Gajewski has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Oncology and 5 papers in Immunology. Recurrent topics in J. Gajewski's work include Hematopoietic Stem Cell Transplantation (12 papers), Virus-based gene therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). J. Gajewski is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Virus-based gene therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). J. Gajewski collaborates with scholars based in United States, United Kingdom and Poland. J. Gajewski's co-authors include Richard E. Champlin, Sergio Giralt, Donna Przepiorka, Issa F. Khouri, Cindy Ippoliti, Börje S. Andersson, April Durett, Jian Lü, Susan Light and Karen R. Cleary and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

J. Gajewski

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Gajewski United States 14 687 399 273 224 185 17 1.0k
N Gratecos France 13 704 1.0× 230 0.6× 306 1.1× 176 0.8× 162 0.9× 46 1.2k
R. Or Israel 16 698 1.0× 410 1.0× 267 1.0× 128 0.6× 64 0.3× 48 1.0k
Daniel Stachel Germany 15 487 0.7× 372 0.9× 226 0.8× 239 1.1× 63 0.3× 45 1.1k
A. M. Stoppa France 17 1.2k 1.7× 362 0.9× 317 1.2× 142 0.6× 83 0.4× 34 1.5k
GE Sale United States 11 931 1.4× 261 0.7× 549 2.0× 225 1.0× 106 0.6× 14 1.4k
J M Vossen Netherlands 12 546 0.8× 332 0.8× 227 0.8× 121 0.5× 112 0.6× 32 906
A Iriondo Spain 19 625 0.9× 185 0.5× 255 0.9× 116 0.5× 75 0.4× 45 1.0k
NH Russell United Kingdom 18 975 1.4× 330 0.8× 401 1.5× 127 0.6× 111 0.6× 32 1.2k
Jeane P. Hester United States 19 381 0.6× 251 0.6× 282 1.0× 101 0.5× 90 0.5× 51 907
AJ Barrett United States 13 963 1.4× 422 1.1× 442 1.6× 127 0.6× 110 0.6× 26 1.3k

Countries citing papers authored by J. Gajewski

Since Specialization
Citations

This map shows the geographic impact of J. Gajewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Gajewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Gajewski more than expected).

Fields of papers citing papers by J. Gajewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Gajewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Gajewski. The network helps show where J. Gajewski may publish in the future.

Co-authorship network of co-authors of J. Gajewski

This figure shows the co-authorship network connecting the top 25 collaborators of J. Gajewski. A scholar is included among the top collaborators of J. Gajewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Gajewski. J. Gajewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Couriel, Daniel R., Adam D. Cohen, Cindy Ippoliti, et al.. (2003). 15 Sirolimus (rapamycin) for treatment of steroid-refractory chronic graft versus host disease. Biology of Blood and Marrow Transplantation. 9(2). 67–68. 8 indexed citations
2.
Champlin, Richard, Nadeem Q. Mirza, J. Gajewski, et al.. (2001). Adenovirus Infections in Adult Recipients of Blood and Marrow Transplants. Clinical Infectious Diseases. 32(6). 871–876. 210 indexed citations
3.
Przepiorka, Donna, Nancy A. Kernan, Cindy Ippoliti, et al.. (2000). Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood. 95(1). 83–89. 199 indexed citations
4.
Przepiorka, Donna, Nancy A. Kernan, Cindy Ippoliti, et al.. (2000). Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood. 95(1). 83–89. 192 indexed citations
5.
Przepiorka, Donna, Koen van Besien, Brian L. Samuels, et al.. (1999). Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma. Annals of Oncology. 10(5). 527–529. 38 indexed citations
6.
Popat, Uday, Richard E. Champlin, William Pugh, et al.. (1998). High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.. Journal of Clinical Oncology. 16(1). 63–69. 48 indexed citations
7.
Ippoliti, Cindy, R. Champlin, Donna Przepiorka, et al.. (1997). Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.. Journal of Clinical Oncology. 15(11). 3350–3354. 32 indexed citations
8.
Gajewski, J., Firoozeh Sahebi, Pamela Crilley, BJ Bolwell, & E. A. Copelan. (1995). Use of the Ohio state busulfan/cyclophasphamide regimen in recipients of matched unrelated donor transplants. Bone Marrow Transplantation. 15(1). 1 indexed citations
9.
Schiller, Gary J., Stephen D. Nimer, Robert Vescio, et al.. (1994). Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma.. PubMed. 14(1). 131–6. 17 indexed citations
10.
Giralt, Sergio, J. P. Hester, Moshe Talpaz, et al.. (1994). G-CSF therapy for patients relapsing after allogeneic bone marrow transplantation. Pathophysiology. 1. 47–47. 1 indexed citations
11.
Hows, J., Richard Szydlo, Claudio Anasetti, et al.. (1992). Unrelated donor marrow transplants for severe acquired aplastic anemia.. PubMed. 10 Suppl 1. 102–6. 27 indexed citations
12.
Champlin, Richard E., Sergio Giralt, Donna Przepiorka, et al.. (1992). Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.. PubMed. 377. 385–94; discussion 395. 18 indexed citations
13.
Champlin, Richard E., J. Gajewski, Stephen D. Nimer, et al.. (1990). Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.. Journal of Clinical Oncology. 8(7). 1199–1206. 59 indexed citations
14.
Champlin, Richard E., W. G. Ho, J. Gajewski, et al.. (1990). Selective depletion of CD8+ T lymphocytes for prevention of graft- versus-host disease after allogeneic bone marrow transplantation. Blood. 76(2). 418–423. 129 indexed citations
15.
Champlin, Richard, W. G. Ho, Stephen D. Nimer, et al.. (1990). BONE MARROW TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA. Transplantation. 49(4). 720–724. 39 indexed citations
16.
Champlin, Richard E., J. Gajewski, Stephen A. Feig, et al.. (1989). Selective depletion of CD8 positive T-lymphocytes for prevention of graft-versus-host disease following allogeneic bone marrow transplantation.. PubMed. 21(1 Pt 3). 2947–8. 14 indexed citations
17.
Gajewski, J.. (1961). Effect of the ingestion of various fats on the fibrinolytic activity in normal subjects and patients with coronary heart disease. Journal of Atherosclerosis Research. 1(3). 222–228. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N Gratecos Breakdown of academic impact, for papers by R. Or Breakdown of academic impact, for papers by Daniel Stachel Breakdown of academic impact, for papers by A. M. Stoppa Breakdown of academic impact, for papers by GE Sale Breakdown of academic impact, for papers by J M Vossen Breakdown of academic impact, for papers by A Iriondo Breakdown of academic impact, for papers by NH Russell Breakdown of academic impact, for papers by Jeane P. Hester Breakdown of academic impact, for papers by AJ Barrett
Rankless by CCL
2026